13.37
Usana Health Sciences Inc stock is traded at $13.37, with a volume of 194.52K.
It is down -1.91% in the last 24 hours and down -37.52% over the past month.
Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).
See More
Previous Close:
$13.63
Open:
$13.76
24h Volume:
194.52K
Relative Volume:
1.39
Market Cap:
$246.85M
Revenue:
$925.94M
Net Income/Loss:
$9.15M
P/E Ratio:
28.12
EPS:
0.4755
Net Cash Flow:
$2.96M
1W Performance:
-13.57%
1M Performance:
-37.52%
6M Performance:
-36.03%
1Y Performance:
-56.21%
Usana Health Sciences Inc Stock (USNA) Company Profile
Name
Usana Health Sciences Inc
Sector
Industry
Phone
(801) 954-7100
Address
3838 WEST PARKWAY BLVD., SALT LAKE CITY, UT
Compare USNA vs JBS, KHC, GIS, MKC, HRL
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
USNA
Usana Health Sciences Inc
|
13.37 | 249.99M | 925.94M | 9.15M | 2.96M | 0.4755 |
|
JBS
Jbs Nv
|
13.65 | 43.16B | 88.25B | 1.91B | -681.64M | 1.6761 |
|
KHC
Kraft Heinz Co
|
25.51 | 29.09B | 24.99B | -5.76B | 3.95B | -4.863 |
|
GIS
General Mills Inc
|
39.20 | 20.38B | 18.42B | -85.30M | 1.63B | -0.1894 |
|
MKC
Mccormick Co Inc
|
54.67 | 14.24B | 7.39B | 1.63B | 1.02B | 6.0085 |
|
HRL
Hormel Foods Corp
|
24.54 | 13.42B | 12.22B | 466.64M | 692.94M | 0.8477 |
Usana Health Sciences Inc Stock (USNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-23-23 | Initiated | Sidoti | Buy |
| Jul-07-22 | Downgrade | Jefferies | Hold → Underperform |
| Apr-14-22 | Initiated | DA Davidson | Neutral |
| Dec-17-20 | Initiated | ROTH Capital | Buy |
| Aug-22-19 | Initiated | Jefferies | Hold |
| Apr-16-19 | Initiated | Tigress Financial | Buy |
| Oct-25-18 | Upgrade | Sidoti | Neutral → Buy |
| Oct-24-18 | Upgrade | Pivotal Research Group | Hold → Buy |
| Apr-23-18 | Downgrade | Pivotal Research Group | Buy → Hold |
| Feb-07-18 | Reiterated | Pivotal Research Group | Buy |
| Jan-24-18 | Downgrade | Sidoti | Buy → Neutral |
| Oct-25-17 | Reiterated | Pivotal Research Group | Buy |
| Jul-26-17 | Reiterated | Pivotal Research Group | Buy |
| May-03-17 | Upgrade | Pivotal Research Group | Hold → Buy |
| May-01-17 | Downgrade | Pivotal Research Group | Buy → Hold |
| Feb-08-17 | Reiterated | Pivotal Research Group | Buy |
| Jul-28-16 | Reiterated | DA Davidson | Neutral |
| Feb-10-16 | Downgrade | DA Davidson | Buy → Neutral |
| Oct-16-15 | Upgrade | Sidoti | Neutral → Buy |
| Sep-16-15 | Upgrade | DA Davidson | Neutral → Buy |
| Aug-06-15 | Downgrade | DA Davidson | Buy → Neutral |
| Aug-05-15 | Upgrade | Pivotal Research Group | Hold → Buy |
| Jun-26-15 | Initiated | DA Davidson | Buy |
View All
Usana Health Sciences Inc Stock (USNA) Latest News
USANA Health Sciences (USNA) sees Renaissance report 5.19% equity stake - Stock Titan
USANA Health Sciences 2Q 2026: Revenue $223.3M, Net loss $(21.4)M, EPS $(1.16) — 10-Q Summary - TradingView
USANA Health Sciences (USNA) swings to Q2 loss after $29.1M Hiya impairment - Stock Titan
5 Must-Read Analyst Questions From USANA’s Q2 Earnings Call - Yahoo Finance
Sidoti Raises Earnings Estimates for USANA Health Sciences - MarketBeat
Why Usana Health Sciences Stock Plummeted This Week - The Motley Fool
Why Usana Health Sciences Stock Plummeted This Week - The Motley Fool
USANA Health Sciences Q2 Earnings Call Highlights - MarketBeat
USANA Health Sciences (NYSE:USNA) Rating Lowered to Strong Sell at Zacks Research - MarketBeat
USANA Health Sciences (NYSE:USNA) Cut to "Hold" at Wall Street Zen - MarketBeat
Sidoti Brokers Decrease Earnings Estimates for USNA - MarketBeat
USANA Health Sciences (USNA) Stock Price, News & Analysis - MarketBeat
USANA Health Sciences, Inc. Just Missed Earnings With A Surprise LossHere Are Analysts Latest Forecasts - Moomoo
Should USANA Health Sciences (USNA) Revisit Its Valuation After Lowered Guidance And Q2 Loss? - Yahoo Finance
USANA Health Sciences (USNA) Stock Sinks After Hiya Impairment And Loss Shock - Sahm
Usana Health Sciences Inc (USNA) (Q2 2026) Earnings Call Highlights: Strategic Pivots Amidst ... - Yahoo Finance
USANA Health Sciences: No Clear Growth Engine Left (Rating Downgrade) (NYSE:USNA) - Seeking Alpha
Earnings call transcript: USANA Health Sciences posts Q2 2026 loss, stock sinks 28% - Investing.com
USANA Reports Q2 2026 Financial Results - Direct Selling News
Why USANA (USNA) Stock Is Nosediving - TradingView
Why is USANA Health Sciences stock collapsing today? - Investing.com
Why is USANA Health Sciences stock collapsing today? By Investing.com - Investing.com Canada
USANA Chairman, CEO Kevin Guest Shares 5 Ways to Make Happiness Happen at Work and Home This August - AOL.com
USANA CEO urges embracing small moments of happ... - Pluang
USANA CEO's Parents Bought a Piano Before a Car—They Still Own It - Stock Titan
USANA Health: Q2 Earnings Snapshot - theheraldreview.com
Lazard Asset Management LLC Invests $1.26 Million in USANA Health Sciences, Inc. $USNA - MarketBeat
USANA Health Sciences (NYSE:USNA) Releases FY 2026 Earnings Guidance - MarketBeat
USANA Health Sciences (USNA) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
USANA (NYSE:USNA) Misses Q2 CY2026 Sales Expectations, Stock Drops 19.2% - Yahoo Finance
USANA Health Sciences (NYSE:USNA) Posts Earnings Results, Misses Estimates By $0.50 EPS - MarketBeat
USANA Reports $223.3 Million Q2 Net Sales and $21.4 Million Loss - Quiver Quantitative
USANA Health Sciences (NYSE: USNA) swings to Q2 loss, trims 2026 forecast - Stock Titan
USANA Updates 2026 Sales Outlook After Hiya, Rise Fall Short - Stock Titan
Earnings To Watch: USANA (USNA) Reports Q2 Results Tomorrow - Yahoo! Finance Canada
USANA Health Sciences, Inc. Revenue Breakdown – NYSE:USNA - TradingView
USANA Health Sciences Inc expected to post earnings of 43 cents a shareEarnings Preview - TradingView
New 12-Week Consumer Study Highlights Visible Skin Benefits with USANA Glow - Nasdaq
USANA Health Sciences Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
How Usana Health Sciences Inc. (USNA) Affects Rotational Strategy Timing - Stock Traders Daily
USANA Health Sciences (USNA) to Announce Earnings on Tuesday - MarketBeat
USANA Health Sciences Inc (USNA) Cash Flow - TradingKey
USANA Health Sciences CIO Benedict Peter Increases Stock Holdings via RSU Vesting and Market Sale - Kalkine Media
Form 4 USANA Health Sciences Inc For: 27 July By Investing.com - Investing.com Canada
USANA Health Sciences Director Nixon J. Scott Acquires 1,632 Restricted Stock Units, Signaling Confidence - Kalkine Media
USANA Health Sciences Inc (USNA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
USANA Health Sciences Inc - TradingKey
USANA Health Sciences Inc (USNA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
USNA|USANA Health Sciences Inc|Price:21.320|Chg%:+0.400 - TradingKey
TradingKey - TradingKey
USANA Renews Partnership with Nordiq Canada - Direct Selling News
Usana Health Sciences Inc Stock (USNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):